• Fund Type: Investment Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Biotech Growth Trust PLC/The

+ Add to Watchlist

BIOG:LN

569.5000 GBp 11.0000 1.97%

As of 11:35:04 ET on 10/23/2014.

Snapshot for Biotech Growth Trust PLC/The (BIOG)

Open: 555.5000 High - Low: 570.0000 - 555.5000 Primary Exchange: London
Volume: 74,834 52-Week Range: 391.0000 - 577.0000 Beta vs NBI: 0.8210

ETF Chart for BIOG

No chart data available.
  • BIOG:LN 569.5000
  • 1D
  • 1M
  • 1Y
558.5000
Interactive BIOG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIOG

The Biotech Growth Trust PLC is a closed-end fund incorporated in the United Kingdom. The aim of the Fund is to achieve capital appreciation through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies.

Inception Date: 1997-06-23 Telephone: +44-20-3008-4910
Managers: RICHARD D KLEMM
Web Site: www.biotechgt.com

Fundamentals for BIOG

NAV (on 2014-10-22) 598.4500
Assets (M) (on 2004-09-30) 28.4000
Shares out (M) 63.78
Market Cap (M) 363.22
% Premium -6.68
Average 52-Week % Premium -5.8152
Fund Leveraged N

Dividends for BIOG

Dividend Type Discontinued
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for BIOG

1-Month +0.81% 1-Year +29.13%
3-Month +16.35% 3-Year +47.13%
Year To Date +19.34% 5-Year +32.63%
Expense Ratio 1.20

Top Fund Holdings for BIOG

Filing Date: 05/31/2014
Name Position Value % of Total
Gilead Sciences Inc 870,800 42,155,162 12.546%
Biogen Idec Inc 213,600 40,654,485 12.100%
Alexion Pharmaceuticals Inc 198,000 19,631,788 5.843%
Illumina Inc 206,300 19,463,425 5.793%
Incyte Corp 532,000 15,712,451 4.676%
Amgen Inc 195,000 13,479,745 4.012%
InterMune Inc 557,000 13,153,349 3.915%
Impax Laboratories Inc 700,000 11,584,941 3.448%
Mylan Inc/PA 368,500 10,947,241 3.258%
Ono Pharmaceutical Co Ltd 240,000 10,940,926 3.256%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil